ArticleJournal of neurology, neurosurgery, and psychiatry2000
Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.
Article in Journal of neurology, neurosurgery, and psychiatry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 107 citations in OpenAlex.
- La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder.Neuropsychiatric disease and treatment · 2017Article
- Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease.Journal of molecular neuroscience : MN · 2011Article
- Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.Journal of molecular neuroscience : MN · 2011Review
- Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.Neurodegenerative disease management · 2011Article
- Visual spatial cognition in neurodegenerative disease.Neurocase · 2010Review
- Imaging-pathologic correlation in corticobasal degeneration.AJNR. American journal of neuroradiology · 2009Article
- Rapidly progressive dementia.Neurologic clinics · 2007Review
- Visuospatial functions in atypical parkinsonian syndromes.Journal of neurology, neurosurgery, and psychiatry · 2006Article
- The clinical assessment of the patient with early dementia.Journal of neurology, neurosurgery, and psychiatry · 2005Review
- Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report.Neurocase · 2004Article
- Presenile dementia syndromes: an update on taxonomy and diagnosis.Journal of neurology, neurosurgery, and psychiatry · 2002Review
- Signature tau neuropathology in gray and white matter of corticobasal degeneration.The American journal of pathology · 2002Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAccording to the existing viewpoint, Corticobasal degeneration (CBD) is thought of as a predominantly extrapyramidal motor disorder that is distinct and unrelated to frontotemporal dementia (FTD), the most common form of non-Alzheimer dementias. A lack of understanding of the aetiopathogenesis, and poor correlation between the pathology and the clinical syndromes, has resulted in a disparity in the classification of cases of non-Alzheimer dementias. This report intends to highlight the overlap between FTD and CBD in the light of the evolution of these terms, and to discuss the implications of these findings on the nosology of CBD and the classification of non-Alzheimer dementias. METHODS AND
resultsTwo cases who presented with cognitive dysfunction, which, on comprehensive neuropsychological testing warranted an antemortem diagnosis of FTD are reported. A detailed necropsy study of their brains, however, favoured a pathological diagnosis of CBD. The literature on the overlap between CBD and FTD is also reviewed.
conclusionsFirstly, evidence is emerging to suggest that the clear distinction drawn between FTD and CBD by the existing viewpoint, needs revision. Secondly, until such time that a comprehensive classification of non-Alzheimer dementias is evolved, it may be better to distinguish between the clinical and pathological levels of description and to classify cases, in vivo, on the basis of the clinical phenotype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.